Return to Home [X]

Exciting News: Introducing the New Essential Evidence Plus!

We are thrilled to announce that a brand-new version of Essential Evidence Plus is on its way! Mark your calendars for the launch date, September 11th, as we are introducing a modern, mobile-first application that will revolutionize your experience. With this update, accessing our valuable content will be easier and more convenient than ever before.

What to Expect from the New Essential Evidence Plus:

  1. Modern Mobile-First Experience: Our new application has been meticulously designed with a mobile-first approach. No matter what device you're using, whether it's a smartphone, tablet, or desktop, you'll enjoy a seamless and intuitive user experience.
  2. Enhanced Accessibility: We understand the importance of accessing content from anywhere, at any time. The new Essential Evidence Plus will provide you with the flexibility to explore our extensive collection of evidence-based resources on the go, making it easier to stay up to date with the latest medical knowledge and interactive tools.
  3. Improved User Interface: We have revamped our user interface to ensure effortless navigation and a visually appealing experience. Finding the information, you need will be quicker and more intuitive, saving you valuable time and effort.

Essential Evidence Plus will be available to users during this transition. However, please note that ability to create new trial and individual subscriptions will not be available from September 8th to September 11th 7:00 AM EST. During this period, we will be working diligently to transfer our existing system to the upgraded platform, ensuring a seamless transition for all users.

We apologize for any inconvenience caused by this temporary interruption. Rest assured, our team is committed to bringing you a superior user experience, and we appreciate your patience and understanding during this time.

Stay Tuned for the New Essential Evidence Plus!

We are counting down the days until September 11th when the new Essential Evidence Plus will be available for you to explore. Get ready to unlock a wealth of evidence-based resources that empower you in your medical decision-making process.

Thank you for your continued support, and we look forward to delivering an exceptional experience with the all-new Essential Evidence Plus!

Essential Evidence Plus

Browse Databases and Tools

Sort by Show per page
  • Ivermectin and permethrin for treating scabies
    Cochrane Systematic Reviews, 2-Apr-2018
  • Ivermectin for onchocercal eye disease (river blindness)
    Cochrane Systematic Reviews, 15-Aug-2012
  • Ivermectin for preventing and treating COVID‐19
    Cochrane Systematic Reviews, 21-Jun-2022
  • Ivermectin treatment in humans for reducing malaria transmission
    Cochrane Systematic Reviews, 29-Jun-2021
  • Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection
    Cochrane Systematic Reviews, 18-Jan-2016
  • Janus kinase inhibitors for the treatment of COVID‐19
    Cochrane Systematic Reviews, 13-Jun-2022
  • Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
    Cochrane Systematic Reviews, 10-Apr-2015
  • Joint lavage for osteoarthritis of the knee
    Cochrane Systematic Reviews, 13-Apr-2010
  • Kangaroo mother care to reduce morbidity and mortality in low birthweight infants
    Cochrane Systematic Reviews, 23-Aug-2016
  • Kava extract versus placebo for treating anxiety
    Cochrane Systematic Reviews, 20-Jan-2003
  • Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
    Cochrane Systematic Reviews, 8-Oct-2021
  • Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder
    Cochrane Systematic Reviews, 12-Sep-2021
  • Ketamine as an adjuvant to opioids for cancer pain
    Cochrane Systematic Reviews, 28-Jun-2017
  • Ketamine for management of acute exacerbations of asthma in children
    Cochrane Systematic Reviews, 14-Nov-2012
  • Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
    Cochrane Systematic Reviews, 27-Apr-1998
  • Ketogenic diets for drug‐resistant epilepsy
    Cochrane Systematic Reviews, 24-Jun-2020
  • Ketoprofen for episodic tension‐type headache in adults
    Cochrane Systematic Reviews, 22-Sep-2016
  • Ketorolac for postoperative pain in children
    Cochrane Systematic Reviews, 7-Jul-2018
  • Ketotifen alone or as additional medication for long‐term control of asthma and wheeze in children
    Cochrane Systematic Reviews, 26-Jan-2004
  • Kinesio taping for rotator cuff disease
    Cochrane Systematic Reviews, 8-Aug-2021

Login or Subscribe


Not Yet a Subscriber?

Doctor with handheld

We offer subscriptions for individuals and institutions

To find out about all the benefits of a year-long subscription to Essential Evidence Plus, click the button below!

Learn More